NOXXON announces EUR 6.2 million equity capital raise including US$ 5 million from US family office - Acuitas Capital, LLC
NOXXON ends the use of variable rate equity financing with Yorkville
NOXXON ends the use of variable rate equity financing with Yorkville
A new Research Training Group aims to decode the complex structure of peptides. The German Research Foundation is to provide EUR 4.5 million in funding for the research
R2R Biofluidics EU project recently received the Austrian Fast Forward Award 2018
Proceeds provide OMEICOS with the financial runway to conduct the Phase II Study PROMISE-AF and continue expansion into ophthalmology through US subsidiary
ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins announced today that it has completed a cell line development project for one of Zymeworks Inc.’s bispecific antibody program which exceeded…
Forbion invests €12.5m from its recently launched Forbion IV fund
OMEICOS is pioneering the development of stable analogs of omega-3 fatty acid metabolites for Cardiovascular Disease and Ophthalmology
Forbion, a leading European life science…
Eyeluminati from India chosen out of 60 applications from 19 countries
10th World Health Summit has kicked off in Berlin/Germany
German Federal Minister of Health Jens Spahn announces long-term support for the core mandate of WHO at the World Health Summit Opening Ceremony in Berlin
World leaders from politics, science, industry and civil society will meet from October 14-16 to discuss the best ways to reach the United Nation health targets